Mutations in the ubiquitin binding protein UBQLN2 impair protein degradation via autophagy and the ubiquitin-proteasome pathway [36,37,38,39], and accumulating evidence shows that this contributes to the development of ALS/FTD [1,9,40]. This evidence concerns the gene UBQLN2 and frontotemporal dementia.